Stay updated on Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.

Latest updates to the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not all be about the study. Revision updated to version v3.3.2.SummaryDifference0.1%

- Check26 days agoChange DetectedThe top government funding/operating status notice was removed from the page.SummaryDifference0.2%

- Check33 days agoChange DetectedTainan City, Taiwan was removed and Tainan, Taiwan was added to the study locations. This aligns site naming with current common usage and improves accuracy for participants seeking nearby sites.SummaryDifference0.0%

- Check41 days agoChange DetectedThe two screenshots show formatting and UI adjustments only, with core study details such as eligibility criteria, interventions, primary outcomes, and listed locations unchanged.SummaryDifference0.3%

- Check69 days agoChange DetectedMajor change: page now carries a government-operating-status notice and a new version tag (v3.2.0) replacing the old one (v3.1.0).SummaryDifference3%

- Check76 days agoChange DetectedThe page updates to revision v3.1.0 and removes several drug-safety related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs).SummaryDifference0.4%

Stay in the know with updates to Guselkumab vs Ustekinumab in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Guselkumab vs Ustekinumab in Psoriasis Clinical Trial page.